(Q37976257)

26 August 2017

title

The emerging role of diffusion-weighted MRI in prostate cancer management (English)

1 reference

magnetic resonance imaging

26 August 2017

main subject

1 reference

1 reference

4

Evis Sala

1 reference

26 August 2017

Edward M Lawrence

1

1 reference

26 August 2017

Vincent J Gnanapragasam

series ordinal

2

1 reference

26 August 2017

Andrew N Priest

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 January 2012

1 reference

26 August 2017

published in

Nature Reviews Urology

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

94-101

1 reference

26 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Imaging prostate cancer: a multidisciplinary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Imaging parameter effects in apparent diffusion coefficient determination of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate Cancer: Comparison of Tumor Visibility on Trace Diffusion-Weighted Images and the Apparent Diffusion Coefficient Map

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Apparent diffusion coefficient histograms may predict low-grade glioma subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Improving apparent diffusion coefficient estimates and elucidating tumor heterogeneity using Bayesian adaptive smoothing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Focal therapy for prostate cancer: possibilities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Role of MRI in minimally invasive focal ablative therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Is it time to consider a role for MRI before prostate biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion MR imaging for monitoring of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Judging New Markers by Their Ability to Improve Predictive Accuracy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.222

31 March 2020

Identifiers

DOI

10.1038/NRUROL.2011.222

1 reference

Dimensions Publication ID

26 August 2017

1007724918

0 references

1 reference